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We congratulate van Till and colleagues on their review
showing that selective decontamination of the digestive tract
(SDD) is more effective than single-drug prophylaxis (SAP) in
reducing yeast colonisation, infection and mortality [1].
The authors claimed that their review differs from our earlier
review, which included paediatric or liver transplant patients.
In our review a subgroup analysis was performed in both
selected and unselected populations, and demonstrated a
significant reduction in yeast carriage and infection in
unselected critically ill patients [2].
van Till and colleagues assessed yeast colonisation, lumping
together ‘positive yeast cultures obtained from sputum, stool,
urine and/or wound’ [1]. The majority of SDD trials reported
positive yeast cultures obtained from surveillance cultures of
throat and rectal swabs, whilst the SAP studies mainly
assessed positive yeast cultures obtained from diagnostic
samples including lower airway secretions, urine and wound
fluid. Grouping together surveillance and diagnostic cultures
may be misleading in interpreting the efficacy of antifungal
interventions.
van Till and colleagues’ review demonstrated a nonsignificant
41% reduction in candidemia by SDD and a 68% significant
reduction by SAP [1]. The authors concluded that SAP
prevents candidemia, whilst SDD does not. We believe that
van Till and colleagues evaluated two different populations,
as the candidemia rates in the control individuals were 3.79%
and 1.69% for SAP and SDD, respectively. A larger sample
size is almost certainly needed for SDD to demonstrate a
significant reduction in candidemia [3].
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SAP = single-drug prophylaxis; SDD = selective decontamination of the digestive tract.